The kits offer patients and physicians an alternative to Pap smears, allowing a patient to administer the swab privately in a healthcare setting.
The FDA approved the kits in May and researchers from the medical device manufacturing company BD are working toward getting an at-home version of the test approved, according to ABC News.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
